John Prescott

Key Research Areas
Associated Researchers

No researchers found.

Associated Organizations

No partner organizations found.

Recent Research Projects

Plasmids and virulence in animal disease isolates of type A Clostridium perfringens

2011/12-2017/18 • $200,000 • PI
There are a number of very important but not-well-characterized intestinal diseases of different animal species associated with the bacterium Clostridium perfringens, which are responsible for serious and often fatal illness. These range from commonly fatal diseases such as haemorrhagic...

Virulence and immunity in Rhodococcus equi

2010/11 • $60,834 • PI
No summary

Patents

VACCINE AGAINST CLOSTRIDIUM PERFRINGENS

There is provided a vaccine for controlling Clostridium perfringens in an imals, and particularly necrotic enteritis in poultry. The vaccine may compr ise a C. perfringens antigenic polypeptide or variant thereof, a nucleic aci d encoding the C. perfringens antigenic polypeptide or variant thereof, or a recombinant cell producing the C. perfringens antigenic polypeptide or vari ant thereof.
Related applications: CA20082685533, EP20080757167, WO2008CA01031

A NOVEL TOXIN IN TYPE A CLOSTRIDIUM PERFRINGENS

The present disclosure relates to a novel toxin of Type A C. perfringens and immunogenic compositions and vaccines thereof. The present disclosure further relates to methods and uses of treating or preventing enteric disease and assays for diagnosing enteric disease in mammals.
Related applications: EP20130794617, CA20132874191, WO2013CA00503

NOVEL TOXINS IN TYPE A CLOSTRIDIUM PERFRINGENS

The present disclosure relates to novel pore-forming toxins of Type A C. perfringens and immunogenic compositions and vaccines thereof. The present disclosure further relates to methods and uses of treating or preventing enteric disease and assays for diagnosing enteric disease.
Related applications: CA20152901333